SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-059441
Filing Date
2022-05-12
Accepted
2022-05-12 16:16:19
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2215302d1_8k.htm   iXBRL 8-K 27135
2 EXHIBIT 99.1 tm2215302d1_ex99-1.htm EX-99.1 57235
6 GRAPHIC tm2215302d1_ex99-1img002.jpg GRAPHIC 3974
  Complete submission text file 0001104659-22-059441.txt   274109

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aptx-20220512.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aptx-20220512_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aptx-20220512_pre.xml EX-101.PRE 22593
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2215302d1_8k_htm.xml XML 3706
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38535 | Film No.: 22918014
SIC: 2834 Pharmaceutical Preparations